Cathie Wood Watch: Ark Buys Into Drug-Discovery, Protein-Testing Firms

The prominent asset manager Cathie Wood, chief executive of Ark Investment Management, on Wednesday bought into a drug-discovery-technology stock, again bulked up on a major cryptocurrency stock, and ...